IL18 and metabolic dysfunction-associated steatohepatitis: In addition, though Tch, AST, IL-18 and MDA levels were also decreased in NASH+HDMCP-siRNA group, it has not reached statistical significance when compared with NASH+NC-siRNA group (Fig 3D).